J Neurol Surg B Skull Base 2013; 74(06): 399-402
DOI: 10.1055/s-0033-1347375
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Successful Management of a Catecholamine-Secreting Glomus Jugulare Tumor with Radiosurgery Alone

Jonathan M. Fussey
1   Department of Otolaryngology, University Hospital Coventry, Coventry, United Kingdom
,
Andras A. Kemeny
2   National Centre for Stereotactic Radiosurgery, Royal Hallamshire Hospital, Sheffield, United Kingdom
,
Sailesh Sankar
3   Department of Clinical Endocrinology, University Hospital Coventry, Coventry, United Kingdom
,
Darius Rejali
1   Department of Otolaryngology, University Hospital Coventry, Coventry, United Kingdom
› Author Affiliations
Further Information

Publication History

31 December 2012

04 March 2013

Publication Date:
22 May 2013 (online)

Abstract

Secretory glomus jugulare tumors are often resected surgically to control the systemic effects of the catecholamines they produce. This involves complex skull base surgery, which carries significant risks and frequent morbidity. Stereotactic radiosurgery (SRS) is a recently recognized treatment for glomus jugulare tumors, though little is known about its use in secretory tumors.

Case Report A young fit patient with a catecholamine-secreting glomus jugulare tumor was treated with SRS alone and over the following 37 months her urinary catecholamine excretion fell to near normal levels, and serial magnetic resonance imaging (MRI) confirmed a reduction in tumor volume.

Discussion Radiosurgery is an accepted treatment for glomus jugulare tumors and is now readily available to skull base surgeons. In this case a catecholamine-secreting tumor was successfully controlled with radiosurgery alone. Further research and long-term follow-up will determine the role of this treatment in the nonsurgical management of secreting glomus jugulare tumors.

 
  • References

  • 1 Heth J. The basic science of glomus jugulare tumors. Neurosurg Focus 2004; 17 (2) E2
  • 2 Burnichon N, Abermil N, Buffet A, Favier J, Gimenez-Roqueplo AP. The genetics of paragangliomas. Eur Ann Otorhinolaryngol Head Neck Dis 2012; 129 (6) 315-318
  • 3 Hafez RFA, Morgan MS, Fahmy OM. The safety and efficacy of gamma knife surgery in management of glomus jugulare tumor. World J Surg Oncol 2010; 8: 76
  • 4 Erickson D, Kudva YC, Ebersold MJ , et al. Benign paragangliomas: clinical presentation and treatment outcomes in 236 patients. J Clin Endocrinol Metab 2001; 86 (11) 5210-5216
  • 5 Guss ZD, Batra S, Li G , et al. Radiosurgery for glomus jugulare: history and recent progress. Neurosurg Focus 2009; 27 (6) E5
  • 6 Spector GJ, Compagno J, Perez CA, Maisel RH, Ogura JH. Glomus jugulare tumors: effects of radiotherapy. Cancer 1975; 35 (5) 1316-1321
  • 7 Gottfried ON, Liu JK, Couldwell WT. Comparison of radiosurgery and conventional surgery for the treatment of glomus jugulare tumors. Neurosurg Focus 2004; 17 (2) E4
  • 8 Pluta RM, Ram Z, Patronas NJ, Keiser H. Long-term effects of radiation therapy for a catecholamine-producing glomus jugulare tumor. Case report. J Neurosurg 1994; 80 (6) 1091-1094
  • 9 Schwaber MK, Gussack GS, Kirkpatrick W. The role of radiation therapy in the management of catecholamine-secreting glomus tumors. Otolaryngol Head Neck Surg 1988; 98 (2) 150-154
  • 10 Liscák R, Vladyka V, Wowra B , et al. Gamma Knife radiosurgery of the glomus jugulare tumour - early multicentre experience. Acta Neurochir (Wien) 1999; 141 (11) 1141-1146
  • 11 Ivan ME, Sughrue ME, Clark AJ , et al. A meta-analysis of tumor control rates and treatment-related morbidity for patients with glomus jugulare tumors. J Neurosurg 2011; 114 (5) 1299-1305
  • 12 Kemeny AA. Contemporary management of jugular paragangliomas (glomus tumours): microsurgery and radiosurgery. Acta Neurochir (Wien) 2009; 151 (5) 419-421
  • 13 Castrucci WA, Chiang VLS, Hulinsky I, Knisely JP. Biochemical and clinical responses after treatment of a catecholamine-secreting glomus jugulare tumor with gamma knife radiosurgery. Head Neck 2010; 32 (12) 1720-1727